Estrogen Receptor Alpha Expression in Ovarian Cancer Predicts Longer Overall Survival
| Autor: | Agnieszka Hałoń, Tserenchunt Gansukh, Manfred Dietel, Hermann Lage, Malgorzata Drag-Zalesinska, Marek Spaczyński, Maciej Zabel, Pawel Surowiak, Verena Materna, Piotr Donizy, Ewa Nowak-Markwitz |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2011 |
| Předmět: |
Cancer Research
medicine.medical_specialty medicine.drug_class Receptor expression Biology Pathology and Forensic Medicine Immunoenzyme Techniques Ovarian cancer Internal medicine Ovarian carcinoma medicine Biomarkers Tumor Tumor Cells Cultured Humans Estrogen receptor beta Retrospective Studies Ovarian Neoplasms Hormone activity Research Estrogen Receptor alpha General Medicine Middle Aged medicine.disease Prognosis Immunohistochemistry Cystadenocarcinoma Serous Endometrial Neoplasms Endocrinology Oncology Nuclear receptor Estrogen Cancer research Female Cisplatin Estrogen receptor alpha Follow-Up Studies |
| Zdroj: | Pathology Oncology Research |
| ISSN: | 1532-2807 1219-4956 |
| Popis: | Estrogen as a potential factor of ovarian carcinogenesis, acts via two nuclear receptors, estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ), but the cellular signal pathways involved are not completely clear so far. In this study we have described the expression of ERα, detected by immunocytochemistry in 11 ovarian carcinoma cell lines and by immunohistochemistry in 43 Federation Internationale des Gyneacologistes et Obstetristes stage III ovarian carcinoma specimens prepared before and after treatment with cisplatin-based schemes. For cisplatin resistance is a major obstacle in the treatment of ovarian carcinoma, analysis of cisplatin sensitivity in 11 ovarian carcinoma cell line was also performed. The strong nuclear ERα expression was only shown in the single A2780P cell line. Expression of ERα in tissue specimens did not reveal any correlations between histopathological parameters (histologic type and grading). We demonstrated a significant association with ERα expression in specimens from primary laparotomies (PL) and cause–specific survival. In the cases terminated by death of the patient, overall immunoreactivity score of ERα expression at PL was significantly lower than in surviving patients. In addition, Kaplan-Meier analysis revealed significantly shorter overall survival time and progression-free time in cases with lower immunoreactivity score of ERα expression at PL. Our findings support the hypothesis that aberrant hormone activity, by way of altered receptor expression, might be an important factor in the malignant transformation of ovarian cancer. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink